Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, September 3, 2019

Public edition |

Newswise Cancer Research Wire for 03-Sep-2019

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Cancer Research

Medical Imaging Rates Continue to Rise Despite Push to Reduce Their Use

Despite a broad campaign among physician groups to reduce the amount of imaging in medicine, the rates of use of CT, MRI and other scans have continued to increase in both the U.S. and Ontario, Canada, according to a new study of more than 135 millio...

– UC Davis Health

JAMA, Sept. 3 2019

Embargo expired on 03-Sep-2019 at 11:00 ET

Cardiovascular Disease Leading Cause of Death World-Wide, but Cancer Rising Cause in Rich Countries: Study

Cardiovascular disease (CVD) is the major cause of death among middle-aged adults around the world; however, in high-income countries deaths from cancer have become twice as frequent as those from CVD.

– McMaster University

The Lancet

Embargo expired on 03-Sep-2019 at 05:00 ET

Providing More Testing Choices Does Not Increase Colorectal Cancer Screening Rates

A study showed that choice of screening options alone does not impact screening rates, but how the choice is offered can alter patient decision-making.

– Perelman School of Medicine at the University of Pennsylvania

JAMA Network Open; P30AG034546; K08CA234326; R01CA213645

Embargo expired on 30-Aug-2019 at 11:00 ET

وجدت دراسة أجرتها Mayo Clinic أن التلاعب وراثيًا بمستوى البروتين في خلايا سرطان القولون يمكن أن يحسِّن من فعالية المعالجة الكيميائية

قد تتحسَّن نتائج سرطان القولون والمستقيم عن طريق تغيير بروتين المناعة التنظيمية وراثيًا في خلايا السرطان، مما يجعل الخلايا أكثر عُرضة ل...

– Mayo Clinic

A manipulação genética do nível de proteínas em células de câncer do cólon pode aumentar a eficácia da quimioterapia, segundo um estudo da Mayo Clinic

Os resultados do câncer colorretal podem ser aprimorados por meio da alteração de uma proteína imunorreguladora nas células cancerígenas, tornando essas células mais vulneráveis à quimioterapia. Isso de acordo com uma nova pesquisa da Mayo C...

– Mayo Clinic

Die genetische Manipulation des Proteinspiegels in Dickdarmkrebszellen kann die Wirksamkeit von Chemotherapie verbessern, so die Ergebnisse der Mayo Clinic-Studie

Die Ergebnisse beim Kolorektalkarzinom können sich durch eine genetische Veränderung eines immunregulatorischen Proteins in Krebszellen verbessern, durch welche die Zellen anfälliger für Chemotherapie werden. Das geht aus der neuen Studie der May...

– Mayo Clinic


Selon une étude de Mayo Clinic, une manipulation génétique du taux de protéines des cellules cancéreuses du côlon peut améliorer l’efficacité de la chimiothérapie


– Mayo Clinic

Nerves Could be Key to Pancreatic Cancer Spread

A couple of molecules that nerve cells use to grow during development could help explain why the most common pancreatic cancers are so difficult to contain and for patients to survive

– Johns Hopkins Medicine

Gastroenterology; CA169702, CA197296, P30 CA006973,

Radiation oncology research and clinical trial results to be featured at ASTRO’s Annual Meeting in Chicago

The American Society for Radiation Oncology (ASTRO) announced today the top-rated studies to be highlighted in the press program for the 2019 ASTRO Annual Meeting. Researchers will present their findings in three news briefings being held September 1...

– American Society for Radiation Oncology (ASTRO)

Manipular genéticamente el nivel de una proteína en células de cáncer de colon mejora eficacia de la quimioterapia, descubre estudio de Mayo Clinic

Los resultados del cáncer colorrectal pueden mejorar cuando se altera genéticamente una proteína que regula la inmunidad de las células cancerosas con el fin de volverlas más vulnerables a la quimioterapia, dice un nuevo estudio de Mayo Clinic. ...

– Mayo Clinic

Delivering Immunotherapy Directly to Brain Tumors

A new study published this week gives insight into how cancer immunotherapies might one day be delivered directly to the brain in order to treat brain tumors.

– Cedars-Sinai

Nature Communications, Aug. 2019

Singapore researchers reveal inflated performance measurements in current enhancer-promoter interaction prediction methods

A study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and the School of Biological Sciences at Nanyang Technological University, Singapore (NTU Singapore) revealed a co...

– National University of Singapore

Nature Genetics

Gold Nanoparticles Used in Photothermal Therapy Shown to be Safe and Effective Treatment for Prostate Cancer

Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate.

– Mount Sinai Health System

Proceedings of the National Academy of Sciences

Cancer Experts and Features

Drug Designed to Treat Metastatic Pancreatic Cancer May Help Extend Life

A drug developed by researchers at the Renaissance School of Medicine at Stony Brook University that targets enzymes involved in the development of pancreatic cancer cells is showing promise for improved treatment of metastatic pancreatic cancer.

– Stony Brook University

Pancreatic cancer patient realizes her gift of longevity

While weeding in her north Seattle garden, Miggie Olsson discusses how she, as a patient, became a unicorn.

– UW Medicine

Birmingham Woman Meets Philadelphia Man Who Saved Her Life Through Bone Marrow Donation

Jada Lucas, a 22-year-old bone marrow recipient from Birmingham, met the bone marrow donor who helped save her life — Jerome Lewis of Philadelphia, Penn. — at donor registry event at Children's of Alabama.

– Children's of Alabama

Leukemia: Not Just One Disease

An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults.

Expert Available

– Rutgers Cancer Institute of New Jersey

Team Aims to Close Rural-Urban Cancer Survival Gap

Researchers from The University of Kansas Cancer Center has received a five-year, $2.25 million grant from the National Cancer Institute to study why there are survival rate disparities in rural parts of Kansas, and how to improve them.

– University of Kansas Cancer Center

September Is Thyroid Cancer Awareness Month

Mount Sinai promotes early detection and shares tips for prevention

– Mount Sinai Health System

Researchers to create quick, low-cost cancer diagnostic

Researchers at the University of Notre Dame have received $2.9 million to develop a new diagnostic platform that could diagnose cancer in as little as three hours by using only one or two drops of blood.

– University of Notre Dame

Back to School!

From maintaining regular check-ups and keeping up to date with recommended vaccinations to a good diet and exercise, some simple tips can help keep youngsters healthy as they head back to class - and are cancer preventive too.

– Rutgers Cancer Institute of New Jersey

Cancer Announcements

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Announces Management of Most Adult Cancers Covered by NCCN Harmonized Guidelines

A collaborative project from the National Comprehensive Cancer Network® (NCCN®), the African Cancer Coalition (ACC), the American Cancer Society (ACS), and others to improve cancer outcomes in Sub-Saharan Africa enters a new phase in Addis Ababa, E...

– National Comprehensive Cancer Network® (NCCN®)

Embargo expired on 28-Aug-2019 at 07:00 ET

NRG Oncology Approves Danbury and Norwalk Hospitals as Primary Sites for Clinical Research

Danbury Hospital and Norwalk Hospital received approval to join NRG Oncology as primary clinical research sites. This means that patients at Danbury Hospital and Norwalk Hospital now have expanded access to the latest clinical trials for breast cance...

– Nuvance Health

Grant Awarded to Study Negative Side Effects of Cancer Treatment Medication

Xinzhu (Shin) Pu, an assistant research professor in Boise State University’s biology department and Biomolecular Research Center, has been awarded a one-year renewable grant of $50,000 by the IDeA Network of Biomedical Research Excellence (Idaho I...

– Boise State University





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 University of Notre Dame

 Nuvance Health

 Stony Brook University

Subscribe / Unsubscribe
Edit my preferences

© 2019 Newswise, Inc. All Rights Reserved.

265 Turkey Sag Trail Suite 102, #110 Palmyra VA 22963 | 434-296-9417

 Contact Us